M Dosani1, S Lucas2, J Wong1, L Weir1, S Lomas1, C Cumayas1, C Fisher3, S Tyldesley1. 1. Department of Radiation Oncology, British Columbia Cancer Agency Vancouver Centre, 600 W 10th Ave, Vancouver, BC. 2. Department of Radiation Oncology, British Columbia Cancer Agency Centre for the Southern Interior, 399 Royal Ave, Kelowna, BC; and. 3. Division of Spine, Department of Orthopedics, University of British Columbia and Vancouver General Hospital, 899 W 12th Ave, Vancouver, BC.
Abstract
BACKGROUND: The Spinal Instability Neoplastic Score (sins) was developed to identify patients with spinal metastases who may benefit from surgical consultation. We aimed to assess the distribution of sins in a population-based cohort of patients undergoing palliative spine radiotherapy (rt) and referral rates to spinal surgery pre-rt. Secondary outcomes included referral to a spine surgeon post-rt, overall survival, maintenance of ambulation, need for re-intervention, and presence of spinal adverse events. METHODS: We retrospectively reviewed ct simulation scans and charts of consecutive patients receiving palliative spine rt between 2012 and 2013. Data were analyzed using Student's t-test, Chi-squared, Fisher's exact, and Kaplan-Meier log-rank tests. Patients were stratified into low (<7) and high (≥7) sins groups. RESULTS: We included 195 patients with a follow-up of 6.1 months. The median sins was 7. The score was 0 to 6 (low, no referral recommended), 7 to 12 (intermediate, consider referral), and 13 to 18 (high, referral suggested) in 34%, 59%, and 7% of patients, respectively. Eleven patients had pre-rt referral to spine surgery, with a surgery performed in 0 of 1 patient with sins 0 to 6, 1 of 7 with sins 7 to 12, and 1 of 3 with sins 13 to 18. Seven patients were referred to a surgeon post-rt with salvage surgery performed in two of those patients. Primary and secondary outcomes did not differ between low and high sins groups. CONCLUSION: Higher sins was associated with pre-rt referral to a spine surgeon, but most patients with high sins were not referred. Higher sins was not associated with shorter survival or worse outcome following rt.
BACKGROUND: The Spinal Instability Neoplastic Score (sins) was developed to identify patients with spinal metastases who may benefit from surgical consultation. We aimed to assess the distribution of sins in a population-based cohort of patients undergoing palliative spine radiotherapy (rt) and referral rates to spinal surgery pre-rt. Secondary outcomes included referral to a spine surgeon post-rt, overall survival, maintenance of ambulation, need for re-intervention, and presence of spinal adverse events. METHODS: We retrospectively reviewed ct simulation scans and charts of consecutive patients receiving palliative spine rt between 2012 and 2013. Data were analyzed using Student's t-test, Chi-squared, Fisher's exact, and Kaplan-Meier log-rank tests. Patients were stratified into low (<7) and high (≥7) sins groups. RESULTS: We included 195 patients with a follow-up of 6.1 months. The median sins was 7. The score was 0 to 6 (low, no referral recommended), 7 to 12 (intermediate, consider referral), and 13 to 18 (high, referral suggested) in 34%, 59%, and 7% of patients, respectively. Eleven patients had pre-rt referral to spine surgery, with a surgery performed in 0 of 1 patient with sins 0 to 6, 1 of 7 with sins 7 to 12, and 1 of 3 with sins 13 to 18. Seven patients were referred to a surgeon post-rt with salvage surgery performed in two of those patients. Primary and secondary outcomes did not differ between low and high sins groups. CONCLUSION: Higher sins was associated with pre-rt referral to a spine surgeon, but most patients with high sins were not referred. Higher sins was not associated with shorter survival or worse outcome following rt.
Authors: Edward Chow; Amanda Hird; Galina Velikova; Colin Johnson; Linda Dewolf; Andrea Bezjak; Jackson Wu; Jesmin Shafiq; Orhan Sezer; Dimitrios Kardamakis; Yvette van der Linden; Brigette Ma; Monica Castro; Palmira Foro Arnalot; Sam Ahmedzai; Mark Clemons; Peter Hoskin; Albert Yee; Michael Brundage; Andrew Bottomley Journal: Eur J Cancer Date: 2008-12-25 Impact factor: 9.162
Authors: Monica S Krishnan; Zachary Epstein-Peterson; Yu-Hui Chen; Yolanda D Tseng; Alexi A Wright; Jennifer S Temel; Paul Catalano; Tracy A Balboni Journal: Cancer Date: 2013-10-02 Impact factor: 6.860
Authors: Charles G Fisher; Anne L Versteeg; Rowan Schouten; Stefano Boriani; Peter P Varga; Laurence D Rhines; Manraj K S Heran; Norio Kawahara; Daryl Fourney; Jeremy J Reynolds; Michael G Fehlings; Ziya L Gokaslan Journal: AJR Am J Roentgenol Date: 2014-10 Impact factor: 3.959
Authors: Daryl R Fourney; Evan M Frangou; Timothy C Ryken; Christian P Dipaola; Christopher I Shaffrey; Sigurd H Berven; Mark H Bilsky; James S Harrop; Michael G Fehlings; Stefano Boriani; Dean Chou; Meic H Schmidt; David W Polly; Roberto Biagini; Shane Burch; Mark B Dekutoski; Aruna Ganju; Peter C Gerszten; Ziya L Gokaslan; Michael W Groff; Norbert J Liebsch; Ehud Mendel; Scott H Okuno; Shreyaskumar Patel; Laurence D Rhines; Peter S Rose; Daniel M Sciubba; Narayan Sundaresan; Katsuro Tomita; Peter P Varga; Luiz R Vialle; Frank D Vrionis; Yoshiya Yamada; Charles G Fisher Journal: J Clin Oncol Date: 2011-06-27 Impact factor: 44.544
Authors: Charles G Fisher; Christian P DiPaola; Timothy C Ryken; Mark H Bilsky; Christopher I Shaffrey; Sigurd H Berven; James S Harrop; Michael G Fehlings; Stefano Boriani; Dean Chou; Meic H Schmidt; David W Polly; Roberto Biagini; Shane Burch; Mark B Dekutoski; Aruna Ganju; Peter C Gerszten; Ziya L Gokaslan; Michael W Groff; Norbert J Liebsch; Ehud Mendel; Scott H Okuno; Shreyaskumar Patel; Laurence D Rhines; Peter S Rose; Daniel M Sciubba; Narayan Sundaresan; Katsuro Tomita; Peter P Varga; Luiz R Vialle; Frank D Vrionis; Yoshiya Yamada; Daryl R Fourney Journal: Spine (Phila Pa 1976) Date: 2010-10-15 Impact factor: 3.468
Authors: Joanne M van der Velden; Anne L Versteeg; Helena M Verkooijen; Charles G Fisher; Edward Chow; F Cumhur Oner; Marco van Vulpen; Lorna Weir; Jorrit-Jan Verlaan Journal: Oncologist Date: 2017-05-03
Authors: Arjun Sahgal; Eshetu G Atenafu; Sam Chao; Ameen Al-Omair; Nicholas Boehling; Ehsan H Balagamwala; Marcelo Cunha; Isabelle Thibault; Lilyana Angelov; Paul Brown; John Suh; Laurence D Rhines; Michael G Fehlings; Eric Chang Journal: J Clin Oncol Date: 2013-08-19 Impact factor: 44.544
Authors: Anne L Versteeg; Joanne M van der Velden; Helena M Verkooijen; Marco van Vulpen; F Cumhur Oner; Charles G Fisher; Jorrit-Jan Verlaan Journal: Oncologist Date: 2015-12-14
Authors: Merel Huisman; Joanne M van der Velden; Marco van Vulpen; Maurice A A J van den Bosch; Edward Chow; F Cumhur Öner; Albert Yee; Helena M Verkooijen; Jorrit-Jan Verlaan Journal: Spine J Date: 2014-04-04 Impact factor: 4.166
Authors: Carrie M Carr; John C Benson; David R DeLone; Felix E Diehn; Dong K Kim; Daniel Ma; Alex A Nagelschneider; Ajay A Madhavan; Derek R Johnson Journal: Neuroradiol J Date: 2022-05-01
Authors: Moritz Lenschow; Maximilian Lenz; Niklas von Spreckelsen; Julian Ossmann; Johanna Meyer; Julia Keßling; Lukas Nadjiri; Sergej Telentschak; Kourosh Zarghooni; Peter Knöll; Moritz Perrech; Eren Celik; Max Scheyerer; Volker Neuschmelting Journal: Cancers (Basel) Date: 2022-04-27 Impact factor: 6.575
Authors: Alexander Rühle; Verlaine Ange Nya Yompang; Simon K B Spohn; Raluca Stoian; Constantinos Zamboglou; Eleni Gkika; Anca-Ligia Grosu; Nils H Nicolay; Tanja Sprave Journal: Radiat Oncol Date: 2022-09-07 Impact factor: 4.309